Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated
Pediatric Cardiology · Pulmonary Atresia with Intact Ventricular Septum

Validation & Orientation: Understanding PA-IVS

At a Glance

Pulmonary Atresia with Intact Ventricular Septum (PA-IVS) is a rare congenital heart defect where the pulmonary valve is blocked. Doctors immediately stabilize the baby using a medication called Prostaglandin E1 (PGE1) to maintain blood flow to the lungs, allowing time to plan life-saving surgery.

Receiving a diagnosis of Pulmonary Atresia with Intact Ventricular Septum (PA-IVS) is a life-changing and overwhelming moment for any parent. The sudden shift from the joy of a new or upcoming arrival to the high-stakes environment of a pediatric cardiac intensive care unit (CICU) is naturally terrifying. It is common for parents to experience significant psychological distress, including symptoms of traumatic stress, anxiety, and depression following a critical heart diagnosis [1][2].

Please know that your reaction—the fear, the confusion, and the “why us?”—is a valid and expected response to an incredibly difficult situation. You are not alone, and while the road ahead is complex, there is a clear, established map for your child’s care.

What is PA-IVS?

When a baby is born with PA-IVS, they often appear blue or purplish (a condition called cyanosis) because their blood is not getting enough oxygen [3]. This visual is terrifying, but it is the outward sign of an inner plumbing issue that the medical team is highly trained to manage.

In a typical heart, the right side pumps blood through the pulmonary valve to the lungs to get oxygen. In a baby with Pulmonary Atresia, this valve is completely “atretic” (closed or blocked), meaning blood cannot flow directly from the heart to the lungs [3]. The term Intact Ventricular Septum means there is no “hole” (VSD) in the wall between the heart’s lower chambers, which makes this condition distinct from other types of pulmonary atresia [4].

Because blood cannot take its normal path, the baby relies on temporary “backdoor” pathways, like the ductus arteriosus (a natural tunnel between heart vessels that normally closes shortly after birth), to get oxygen to the lungs [5]. PA-IVS is rare, accounting for less than 1% of all congenital heart defects [4].

Three Stabilizing Facts

While the diagnosis is serious and requires immediate medical intervention, several foundational truths can help anchor you during this time.

1. There is an established pathway for your child

PA-IVS is not an “unknown” to the medical community. While every baby is unique, surgeons and cardiologists use specific measurements to determine which of three standard surgical pathways is best for your child [6][7]. Read more about Treatment Pathways.

2. Medical teams can stabilize your baby immediately

Immediately after birth, the priority is keeping the “backdoor” pathway open so oxygen can reach the lungs. Doctors do this using a life-saving medication called Prostaglandin E1 (PGE1) [5][8]. This infusion prevents the ductus arteriosus from closing, providing time to plan the next steps [9]. Read more about Initial Stabilization.

3. Long-term survival is excellent after repair

The most reassuring fact for many families is the long-term outlook. Children who complete their intended surgical pathway have excellent survival rates into adulthood [10]. For those who reach definitive repair, 20-year survival rates have been reported as high as 90% to 98%, depending on the specific type of repair [10]. Read more about Survivorship & Long-term Monitoring.

Navigating This Guide

This guide is designed to help you understand your child’s diagnosis and partner with your medical team. You can explore the following topics:

The transition from “expectant parent” to “heart parent” is a heavy one. Your baby’s medical team is trained specifically for this rare condition. They have the tools to stabilize your child today and the surgical expertise to build a path toward their future. Your role as a parent—providing love, presence, and advocacy—is the one thing the medical team cannot do, and it is the most important job of all [11].

Common questions in this guide

What is PA-IVS in a newborn?
Pulmonary Atresia with Intact Ventricular Septum (PA-IVS) is a rare heart defect where the valve controlling blood flow from the heart to the lungs is completely blocked. It also means there is no hole between the heart's lower chambers, making it difficult for the baby to get enough oxygen.
Why does a baby with PA-IVS appear blue?
Babies with PA-IVS often appear blue or purplish, a condition called cyanosis. This happens because the blocked pulmonary valve prevents blood from reaching the lungs to get oxygen.
How do doctors stabilize a baby born with PA-IVS?
Immediately after birth, doctors use a life-saving medication called Prostaglandin E1 (PGE1). This medicine keeps a natural connection called the ductus arteriosus open, allowing oxygen-poor blood to reach the lungs until surgery can be performed.
What is the long-term survival rate for babies with PA-IVS?
Children who successfully complete their surgical repair pathway have excellent long-term outlooks. While individual outcomes vary depending on the specific repair, 20-year survival rates can be as high as 90 to 98 percent.
What is a tricuspid valve Z-score and why does it matter for PA-IVS?
The tricuspid valve Z-score is a measurement cardiologists use to assess the size of the valve on the right side of the heart. This measurement is crucial because it helps the surgical team determine the most effective treatment pathway for your child.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is our child's tricuspid valve Z-score, and how does that influence their specific surgical pathway?
  2. 2.Does our baby have right ventricle-dependent coronary circulation (RVDCC)? How was this confirmed?
  3. 3.What are the specific signs of apnea or side effects we should watch for while our baby is on PGE1?
  4. 4.How many infants with PA-IVS does this surgical team treat each year, and what are their typical outcomes?
  5. 5.What psychological support services or parent support groups are available at this hospital for families in the NICU/CICU?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Parents' experiences and psychosocial problems related to their preterm infants with congenital heart disease hospitalized in the neonatal intensive care unit: A descriptive phenomenological study.

    Sabaz N, Ciydem E, Tosun S, et al.

    Journal of pediatric nursing 2026; (86()):383-395 doi:10.1016/j.pedn.2025.11.033.

    PMID: 41314151
  2. 2

    Role alteration predicts anxiety and depressive symptoms in parents of infants with congenital heart disease: a pilot study.

    Lisanti AJ, Kumar A, Quinn R, et al.

    Cardiology in the young 2021; (31(11)):1842-1849 doi:10.1017/S1047951121001037.

    PMID: 33818351
  3. 3

    Generation of an induced pluripotent stem cell line NCHi003-A from a 11-year-old male with pulmonary atresia with intact ventricular septum (PA-IVS).

    Contreras J, Alonzo M, Ye S, et al.

    Stem cell research 2022; (64()):102893 doi:10.1016/j.scr.2022.102893.

    PMID: 35987120
  4. 4

    Pulmonary atresia with intact ventricular septum and congenital left ventricular aneurysm.

    Ng B, Hickok R, Stapleton G, Karl T

    Cardiology in the young 2018; (28(6)):876-878 doi:10.1017/S1047951117002992.

    PMID: 29679992
  5. 5

    Stenting of the ductus arteriosus for ductal-dependent pulmonary blood flow-current techniques and procedural considerations.

    Aggarwal V, Petit CJ, Glatz AC, et al.

    Congenital heart disease 2019; (14(1)):110-115 doi:10.1111/chd.12709.

    PMID: 30811792
  6. 6

    Commentary: Despite best intentions: Developing better strategies for patients with pulmonary atresia with intact ventricular septum.

    Barron DJ, Vanderlaan RD

    The Journal of thoracic and cardiovascular surgery 2022; (164(5)):1289-1290 doi:10.1016/j.jtcvs.2021.12.038.

    PMID: 34998589
  7. 7

    Pulmonary Atresia With Intact Ventricular Septum With Borderline Tricuspid Valve: How Small Is Too Small.

    LaPar DJ, Bacha E

    Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual 2019; (22()):27-31 doi:10.1053/j.pcsu.2019.02.007.

    PMID: 31027561
  8. 8

    Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.

    Aykanat A, Yavuz T, Özalkaya E, et al.

    Pediatric cardiology 2016; (37(1)):131-4 doi:10.1007/s00246-015-1251-0.

    PMID: 26260095
  9. 9

    Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines?

    Vari D, Xiao W, Behere S, et al.

    Cardiology in the young 2021; (31(1)):63-70 doi:10.1017/S1047951120003297.

    PMID: 33140712
  10. 10

    Long-term outcomes after intervention for pulmonary atresia with intact ventricular septum.

    Wright LK, Knight JH, Thomas AS, et al.

    Heart (British Cardiac Society) 2019; (105(13)):1007-1013 doi:10.1136/heartjnl-2018-314124.

    PMID: 30712000
  11. 11

    "There's no acknowledgement of what this does to people": A qualitative exploration of mental health among parents of children with critical congenital heart defects.

    Woolf-King SE, Arnold E, Weiss S, Teitel D

    Journal of clinical nursing 2018; (27(13-14)):2785-2794 doi:10.1111/jocn.14275.

    PMID: 29345005

This guide provides general orientation information about PA-IVS for parents and caregivers. It does not replace professional medical advice from your pediatric cardiologist or surgical team.

Get notified when new evidence is published on Pulmonary atresia-intact ventricular septum syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.